199 related articles for article (PubMed ID: 28807937)
1. HNF1B Loss Exacerbates the Development of Chromophobe Renal Cell Carcinomas.
Sun M; Tong P; Kong W; Dong B; Huang Y; Park IY; Zhou L; Liu XD; Ding Z; Zhang X; Bai S; German P; Powell R; Wang Q; Tong X; Tannir NM; Matin SF; Rathmell WK; Fuller GN; McCutcheon IE; Walker CL; Wang J; Jonasch E
Cancer Res; 2017 Oct; 77(19):5313-5326. PubMed ID: 28807937
[TBL] [Abstract][Full Text] [Related]
2. miR-28-5p promotes chromosomal instability in VHL-associated cancers by inhibiting Mad2 translation.
Hell MP; Thoma CR; Fankhauser N; Christinat Y; Weber TC; Krek W
Cancer Res; 2014 May; 74(9):2432-43. PubMed ID: 24491803
[TBL] [Abstract][Full Text] [Related]
3. Expression changes of the MAD mitotic checkpoint gene family in renal cell carcinomas characterized by numerical chromosome changes.
Pinto M; Soares MJ; Cerveira N; Henrique R; Ribeiro FR; Oliveira J; Jerónimo C; Teixeira MR
Virchows Arch; 2007 Apr; 450(4):379-85. PubMed ID: 17333263
[TBL] [Abstract][Full Text] [Related]
4. Analysis of expression, epigenetic, and genetic changes of HNF1B in 130 kidney tumours.
Bártů M; Hojný J; Hájková N; Michálková R; Krkavcová E; Hadravský L; Kleissnerová L; Bui QH; Stružinská I; Němejcová K; Čapoun O; Šlemendová M; Dundr P
Sci Rep; 2020 Oct; 10(1):17151. PubMed ID: 33051485
[TBL] [Abstract][Full Text] [Related]
5. HNF1β and S100A1 are useful biomarkers for distinguishing renal oncocytoma and chromophobe renal cell carcinoma in FNA and core needle biopsies.
Conner JR; Hirsch MS; Jo VY
Cancer Cytopathol; 2015 May; 123(5):298-305. PubMed ID: 25739652
[TBL] [Abstract][Full Text] [Related]
6. Integrative bioinformatics links HNF1B with clear cell carcinoma and tumor-associated thrombosis.
Cuff J; Salari K; Clarke N; Esheba GE; Forster AD; Huang S; West RB; Higgins JP; Longacre TA; Pollack JR
PLoS One; 2013; 8(9):e74562. PubMed ID: 24040285
[TBL] [Abstract][Full Text] [Related]
7. Underexpression of hepatocyte nuclear factor-1β in chromophobe renal cell carcinoma.
Wang CC; Mao TL; Yang WC; Jeng YM
Histopathology; 2013 Mar; 62(4):589-94. PubMed ID: 23237209
[TBL] [Abstract][Full Text] [Related]
8. Genomic and metabolic characterization of a chromophobe renal cell carcinoma cell line model (UOK276).
Yang Y; Vocke CD; Ricketts CJ; Wei D; Padilla-Nash HM; Lang M; Sourbier C; Killian JK; Boyle SL; Worrell R; Meltzer PS; Ried T; Merino MJ; Metwalli AR; Linehan WM
Genes Chromosomes Cancer; 2017 Oct; 56(10):719-729. PubMed ID: 28736828
[TBL] [Abstract][Full Text] [Related]
9. High-Grade, Nonsarcomatoid Chromophobe Renal Cell Carcinoma: A Series of 22 Cases With Novel Molecular Features on a Subset.
Baraban EG; Elias R; Lin MT; Ged Y; Zhu J; Pallavajjala A; Singla N; Lotan TL; Argani P; Eshleman JR; Epstein JI
Mod Pathol; 2024 May; 37(5):100472. PubMed ID: 38492778
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous reduction of MAD2 and BUBR1 expression induces mitotic spindle alterations associated with p53 dependent cell cycle arrest and death.
Lentini L; Piscitello D; Veneziano L; Di Leonardo A
Cell Biol Int; 2014 Aug; 38(8):933-41. PubMed ID: 24687487
[TBL] [Abstract][Full Text] [Related]
11. Next-Generation Sequencing to Detect Deletion of RB1 and ERBB4 Genes in Chromophobe Renal Cell Carcinoma: A Potential Role in Distinguishing Chromophobe Renal Cell Carcinoma from Renal Oncocytoma.
Liu Q; Cornejo KM; Cheng L; Hutchinson L; Wang M; Zhang S; Tomaszewicz K; Cosar EF; Woda BA; Jiang Z
Am J Pathol; 2018 Apr; 188(4):846-852. PubMed ID: 29353061
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the mitotic checkpoint genes BUB1 and BUBR1 is associated with genomic complexity in clear cell kidney carcinomas.
Pinto M; Vieira J; Ribeiro FR; Soares MJ; Henrique R; Oliveira J; Jerónimo C; Teixeira MR
Cell Oncol; 2008; 30(5):389-95. PubMed ID: 18791270
[TBL] [Abstract][Full Text] [Related]
13. The ARF tumor suppressor prevents chromosomal instability and ensures mitotic checkpoint fidelity through regulation of Aurora B.
Britigan EM; Wan J; Zasadil LM; Ryan SD; Weaver BA
Mol Biol Cell; 2014 Sep; 25(18):2761-73. PubMed ID: 25057018
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Review of Numerical Chromosomal Aberrations in Chromophobe Renal Cell Carcinoma Including Its Variant Morphologies.
Alaghehbandan R; Trpkov K; Tretiakova M; Luis AS; Rogala JD; Hes O
Adv Anat Pathol; 2021 Jan; 28(1):8-20. PubMed ID: 33021507
[TBL] [Abstract][Full Text] [Related]
15. Chromophobe renal cell carcinoma: New genetic and metabolic insights.
Zhang L; Henske EP
Urol Oncol; 2020 Aug; 38(8):678-681. PubMed ID: 32444178
[TBL] [Abstract][Full Text] [Related]
16. Endocytosis-Mediated Replenishment of Amino Acids Favors Cancer Cell Proliferation and Survival in Chromophobe Renal Cell Carcinoma.
Xiao Y; Rabien A; Buschow R; Amtislavskiy V; Busch J; Kilic E; Villegas SL; Timmermann B; Schütte M; Mielke T; Yaspo ML; Jung K; Meierhofer D
Cancer Res; 2020 Dec; 80(24):5491-5501. PubMed ID: 33115803
[TBL] [Abstract][Full Text] [Related]
17. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive review of chromophobe renal cell carcinoma.
Garje R; Elhag D; Yasin HA; Acharya L; Vaena D; Dahmoush L
Crit Rev Oncol Hematol; 2021 Apr; 160():103287. PubMed ID: 33753250
[TBL] [Abstract][Full Text] [Related]
19. Expression of mitotic checkpoint proteins BUB1B and MAD2L1 in salivary duct carcinomas.
Ko YH; Roh JH; Son YI; Chung MK; Jang JY; Byun H; Baek CH; Jeong HS
J Oral Pathol Med; 2010 Apr; 39(4):349-55. PubMed ID: 20040022
[TBL] [Abstract][Full Text] [Related]
20. Morphological, immunohistochemical, and chromosomal analysis of multicystic chromophobe renal cell carcinoma, an architecturally unusual challenging variant.
Foix MP; Dunatov A; Martinek P; Mundó EC; Suster S; Sperga M; Lopez JI; Ulamec M; Bulimbasic S; Montiel DP; Alaghehbandan R; Peckova K; Pivovarcikova K; Ondrej D; Rotterova P; Skenderi F; Prochazkova K; Dusek M; Hora M; Michal M; Hes O
Virchows Arch; 2016 Dec; 469(6):669-678. PubMed ID: 27631338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
